Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
Open Access
- 1 August 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (3), 881-888
- https://doi.org/10.1182/blood-2003-10-3402
Abstract
Cerebral X-linked adrenoleukodystrophy (X-ALD) is a disorder of very-long-chain fatty acid metabolism, adrenal insufficiency, and cerebral demyelination. Death occurs within 2 to 5 years of clinical onset without hematopoietic cell transplantation (HCT). One hundred twenty-six boys with X-ALD received HCT from 1982 to 1999. Survival, engraftment, and acute graft-versus-host disease were studied. Degree of disability associated with neurologic and neuropsychological function and cerebral demyelination were evaluated before and after HCT. Complete data were available and analyzed for 94 boys with cerebral X-ALD. The estimated 5- and 8-year survival was 56%. The leading cause of death was disease progression. Donor-derived engraftment occurred in 86% of patients. Demyelination involved parietal-occipital lobes in 90%, leading to visual and auditory processing deficits in many boys. Overall 5-year survival of 92% in patients with 0 or 1 neurologic deficits and magnetic resonance imaging (MRI) severity score less than 9 before HCT was superior to survival for all others (45%; P < .01). Baseline neurologic and neuropsychological function, degree of disability, and neuroradiologic status predicted outcomes following HCT. In this first comprehensive report of the international HCT experience for X-ALD, we conclude that boys with early-stage disease benefit from HCT, whereas boys with advanced disease may be candidates for experimental therapies.Keywords
This publication has 20 references indexed in Scilit:
- Two novel mutations in the adrenoleukodystrophy gene in two unrelated Japanese families and the long-term effect of bone marrow transplantationJournal of the Neurological Sciences, 2000
- Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophyThe Lancet, 2000
- Bone marrow transplantation for the treatment of X‐linked adrenoleukodystrophyJournal of Inherited Metabolic Disease, 2000
- Bone marrow–derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseasesExperimental Hematology, 1999
- Matched Unrelated Human Umbilical Cord Blood Transplantation for X-Linked AdrenoleukodystrophyJournal of Pediatric Hematology/Oncology, 1998
- Treatment of adrenoleukodystrophy with bone marrow transplantationActa Paediatrica, 1997
- The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndromeJournal of Inherited Metabolic Disease, 1995
- Reversal of Early Neurologic and Neuroradiologic Manifestations of X-Linked Adrenoleukodystrophy by Bone Marrow TransplantationThe New England Journal of Medicine, 1990
- Bone marrow transplant in adrenoleukodystrophyNeurology, 1984
- AdrenoleukodystrophyArchives of Neurology, 1975